C8 Lactosyl(β) Ceramide (d18:1/8:0)
| Catalog Number | BL-M001110 |
| CAS Number | 384842-72-2 |
| Description | C8 Lactosyl(β) Ceramide (d18:1/8:0) Investigated extensively for its pivotal function in modulating intricate cell signaling cascades and its promising applicability as a critical therapeutic target in pathologies like cancer and neurodegenerative ailments. |
| {[VisualName]} |  |
| IUPAC Name | N-[(E,2S,3R)-1-[(2R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]octanamide |
| Synonyms | D-lactosyl-β-1,1' N-octanoyl-D-erythro-sphingosine; C8 β-D-lactosyl ceramide; N-(octanoyl)-1-β-lactosyl-sphing-4-enine |
| Molecular Weight | 749.97 |
| Molecular Formula | C38H71NO13 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 60.86%, H 9.54%, N 1.87%, O 27.73% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)NC(=O)CCCCCCC)O |
| InChI | InChI=1S/C38H71NO13/c1-3-5-7-9-10-11-12-13-14-15-16-18-19-21-27(42)26(39-30(43)22-20-17-8-6-4-2)25-49-37-35(48)33(46)36(29(24-41)51-37)52-38-34(47)32(45)31(44)28(23-40)50-38/h19,21,26-29,31-38,40-42,44-48H,3-18,20,22-25H2,1-2H3,(H,39,43)/b21-19+/t26-,27+,28?,29?,31-,32?,33?,34?,35?,36+,37+,38-/m0/s1 |
| InChI Key | JUCWRRXMPGRQOG-WKSBFREFSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
